Title : Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.

Pub. Date : 2012 Jan

PMID : 22018727






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Primary Hyperoxaluria Type I (PH1) is a disorder of glyoxylate metabolism caused by mutations in the human AGXT gene encoding liver peroxisomal alanine:glyoxylate aminotransferase (AGT), a pyridoxal 5"-phosphate (PLP) dependent enzyme. glyoxylic acid alanine--glyoxylate and serine--pyruvate aminotransferase Homo sapiens
2 Primary Hyperoxaluria Type I (PH1) is a disorder of glyoxylate metabolism caused by mutations in the human AGXT gene encoding liver peroxisomal alanine:glyoxylate aminotransferase (AGT), a pyridoxal 5"-phosphate (PLP) dependent enzyme. glyoxylic acid alanine--glyoxylate and serine--pyruvate aminotransferase Homo sapiens
3 Primary Hyperoxaluria Type I (PH1) is a disorder of glyoxylate metabolism caused by mutations in the human AGXT gene encoding liver peroxisomal alanine:glyoxylate aminotransferase (AGT), a pyridoxal 5"-phosphate (PLP) dependent enzyme. glyoxylic acid alanine--glyoxylate and serine--pyruvate aminotransferase Homo sapiens
4 Primary Hyperoxaluria Type I (PH1) is a disorder of glyoxylate metabolism caused by mutations in the human AGXT gene encoding liver peroxisomal alanine:glyoxylate aminotransferase (AGT), a pyridoxal 5"-phosphate (PLP) dependent enzyme. glyoxylic acid alanine--glyoxylate and serine--pyruvate aminotransferase Homo sapiens